Skip to content
Disclosery

PharVision Advisers, LLC: ASAN position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of PharVision Advisers, LLC on ASAN, newest first. How the timeline and the estimate are built.

PharVision Advisers, LLC held 10,309 ASAN shares at 2026-06-30 per its 13F-HR filed 2026-08-11.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 10,309 shares
    Change vs previous 13F -8,432 shares

    1.36% of the 13F portfolio, value $72,163.

    13F-HR 0001420506-26-001505 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F/A 18,741 shares
    Change vs previous 13F -30,450 shares

    1.22% of the 13F portfolio, value $119,942.

    13F-HR/A 0001420506-26-000909 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 49,191 shares
    Change vs previous 13F +32,877 shares

    0.34% of the 13F portfolio, value $674,409.

    13F-HR 0001420506-26-000567 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 16,314 shares
    Change vs previous 13F +6,191 shares

    0.12% of the 13F portfolio, value $217,955.

    13F-HR 0001420506-25-003453 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 10,123 shares
    Change vs previous 13F not available

    0.2% of the 13F portfolio, value $136,661.

    13F-HR 0001420506-25-001926 filed by PharVision Advisers, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).